The European Commission decision is expected within 67 days of the CHMP opinion Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative
Palovarotene is the first medicine to be submitted for regulatory approval for fibrodysplasia ossificans progressiva (FOP), an ultra-rare disease with an estimated prevalence of 1.36 per million individuals
STOCKHOLM, SE / ACCESSWIRE / May 26, 2023 / Re:NewCell AB (publ) (FRA:6QP)(STO:RENEW) Renewcell was announced winner of the Sustainable Textile Innovation category of the annual Drapers Sustainable Fashion
TOKYO, May 26, 2023 - (JCN Newswire) - TOYOTA GAZOO Racing World Rally Team will take on one of the toughest challenges of the season at Rally Italia Sardegna on June 1-4, looking to maintain its recent
VIENNA, VA / ACCESSWIRE / May 26, 2023 / MicroHealth LLC, a leading Health Information Technology company, is proud to announce its inclusion in the 2023 Washington Business Journal Corporate Diversity